ARCA biopharma, Inc. - stock earnings
ABIO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -1.1 million USD | ? USD |
| 2023Q3 | -1.4 million USD | ? USD |
| 2023Q2 | -958000 USD | ? USD |
| 2023Q1 | -896000 USD | ? USD |
| 2022Q4 | -800000 USD | ? USD |
| 2022Q3 | -2.1 million USD | ? USD |
| 2022Q2 | -3.1 million USD | ? USD |
| 2022Q1 | -3.3 million USD | ? USD |
| 2021Q4 | -5.7 million USD | ? USD |
| 2021Q3 | -4.7 million USD | ? USD |
| 2021Q2 | -4.8 million USD | ? USD |
| 2021Q1 | -4.1 million USD | ? USD |
| 2020Q4 | -5.1 million USD | ? USD |
| 2020Q3 | -2.0 million USD | ? USD |
| 2020Q2 | -1.3 million USD | ? USD |
| 2020Q1 | -1.3 million USD | ? USD |
| 2019Q4 | -1.2 million USD | ? USD |
| 2019Q3 | -1.2 million USD | ? USD |
| 2019Q2 | -1.4 million USD | ? USD |
| 2019Q1 | -1.7 million USD | ? USD |
| 2018Q4 | -1.5 million USD | ? USD |
| 2018Q3 | -1.6 million USD | ? USD |
| 2018Q2 | -2.1 million USD | ? USD |
| 2018Q1 | -2.7 million USD | ? USD |
| 2017Q4 | -4.2 million USD | ? USD |
| 2017Q3 | -4.4 million USD | ? USD |
| 2017Q2 | -5.5 million USD | ? USD |
| 2017Q1 | -4.3 million USD | ? USD |
| 2016Q4 | -4.3 million USD | ? USD |
| 2016Q3 | -4.7 million USD | ? USD |
| 2016Q2 | -3.9 million USD | ? USD |
| 2016Q1 | -3.6 million USD | ? USD |
| 2015Q4 | -3.2 million USD | ? USD |
| 2015Q3 | -2.8 million USD | ? USD |
| 2015Q2 | -2.7 million USD | ? USD |
| 2015Q1 | -2.7 million USD | ? USD |
| 2014Q4 | -2.6 million USD | ? USD |
| 2014Q3 | -2.3 million USD | ? USD |
| 2014Q2 | -2.4 million USD | ? USD |
| 2014Q1 | -2.4 million USD | ? USD |
| 2013Q4 | -2.9 million USD | ? USD |
| 2013Q3 | -1.7 million USD | ? USD |
| 2013Q2 | -1.2 million USD | ? USD |
| 2013Q1 | -1.1 million USD | ? USD |
| 2012Q4 | -840000 USD | ? USD |
| 2012Q3 | -927000 USD | ? USD |
| 2012Q2 | -1.1 million USD | ? USD |
| 2012Q1 | -1.4 million USD | ? USD |
| 2011Q4 | -1.6 million USD | ? USD |
| 2011Q3 | -1.8 million USD | ? USD |
| 2011Q2 | 294000 USD | ? USD |
| 2011Q1 | -2.2 million USD | ? USD |
| 2010Q4 | -1.6 million USD | ? USD |
| 2010Q3 | -2.1 million USD | ? USD |
| 2010Q2 | -2.3 million USD | ? USD |
| 2010Q1 | -2.4 million USD | ? USD |
| 2009Q4 | -6.2 million USD | ? USD |
| 2009Q3 | -4.3 million USD | ? USD |
| 2009Q2 | -8.6 million USD | ? USD |
| 2009Q1 | 9.9 million USD | 63000 USD |
| 2008Q4 | -2.8 million USD | 63000 USD |
| 2008Q3 | -8.5 million USD | 63000 USD |
| 2008Q2 | -231000 USD | 45.1 million USD |
| 2008Q1 | -18.4 million USD | 63000 USD |
| 2007Q4 | -11.6 million USD | 63000 USD |
| 2007Q3 | -14.4 million USD | 63000 USD |
| 2007Q2 | 29.0 million USD | 45.8 million USD |
| 2007Q1 | -15.3 million USD | 910000 USD |
| 2006Q4 | -65.3 million USD | 910000 USD |
| 2006Q3 | -26.7 million USD | 908000 USD |
| 2006Q2 | -18.9 million USD | 1.0 million USD |
| 2006Q1 | -19.7 million USD | 1.1 million USD |
| 2005Q4 | -21.5 million USD | 183000 USD |
| 2005Q3 | -18.5 million USD | 123000 USD |
| 2005Q2 | -17.0 million USD | 197000 USD |
| 2005Q1 | -14.7 million USD | 42000 USD |
| 2004Q4 | -13.0 million USD | -2.0 million USD |
| 2004Q3 | -10.9 million USD | 666000 USD |
| 2004Q2 | -11.0 million USD | 910000 USD |
| 2004Q1 | -17.7 million USD | 642000 USD |
| 2003Q4 | -9.4 million USD | 350000 USD |
| 2003Q3 | -10.9 million USD | 262000 USD |
| 2003Q2 | -16.3 million USD | 394000 USD |
| 2003Q1 | -13.6 million USD | 1.3 million USD |
| 2002Q4 | -16.5 million USD | 3.5 million USD |
| 2002Q3 | -1.4 million USD | 11.0 million USD |
| 2002Q2 | -8.1 million USD | 6.7 million USD |
| 2002Q1 | -11.4 million USD | 7.1 million USD |
| 2001Q4 | -11.4 million USD | 7.1 million USD |
| 2001Q3 | -10.0 million USD | 5.9 million USD |
| 2001Q2 | -8.4 million USD | 6.0 million USD |
| 2001Q1 | -6.7 million USD | 4.3 million USD |
| 2000Q4 | -6.7 million USD | 4.3 million USD |
| 2000Q3 | -4.1 million USD | 5.9 million USD |
| 2000Q2 | -5.1 million USD | 3.6 million USD |
| 2000Q1 | -6.3 million USD | 1.8 million USD |
| 1999Q4 | -5.0 million USD | 1.1 million USD |
| 1999Q3 | -4.3 million USD | 1.5 million USD |
| 1999Q2 | -4.5 million USD | 1.0 million USD |
| 1999Q1 | -4.6 million USD | 2.8 million USD |
| 1998Q4 | -4.3 million USD | 2.9 million USD |
| 1998Q3 | -5.5 million USD | 1.4 million USD |
| 1998Q2 | -3.9 million USD | 2.7 million USD |
| 1998Q1 | -2.7 million USD | 2.7 million USD |
| 1997Q4 | -1.5 million USD | 2.4 million USD |
| 1997Q3 | -1.6 million USD | 2.4 million USD |
| 1997Q2 | -1.4 million USD | 1.1 million USD |
| 1997Q1 | -1.9 million USD | 300000 USD |
ABIO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -5.3 million USD | ? USD |
| 2022 | -9.3 million USD | ? USD |
| 2021 | -19.2 million USD | ? USD |
| 2020 | -9.7 million USD | ? USD |
| 2019 | -5.5 million USD | ? USD |
| 2018 | -7.9 million USD | ? USD |
| 2017 | -18.5 million USD | ? USD |
| 2016 | -16.5 million USD | ? USD |
| 2015 | -11.4 million USD | ? USD |
| 2014 | -9.7 million USD | ? USD |
| 2013 | -6.9 million USD | ? USD |
| 2012 | -4.3 million USD | ? USD |
| 2011 | -5.4 million USD | ? USD |
| 2010 | -8.4 million USD | ? USD |
| 2009 | -9.1 million USD | ? USD |
| 2008 | -29.9 million USD | 15.3 million USD |
| 2007 | -12.3 million USD | 46.9 million USD |
| 2006 | -130.6 million USD | 3.9 million USD |
| 2005 | -71.6 million USD | 545000 USD |
| 2004 | -52.5 million USD | 195000 USD |
| 2003 | -50.2 million USD | 2.3 million USD |
| 2002 | -45.0 million USD | 26.4 million USD |
| 2001 | -36.5 million USD | 24.6 million USD |
| 2000 | -22.3 million USD | 15.6 million USD |
| 1999 | -18.5 million USD | 6.4 million USD |
| 1998 | -16.4 million USD | 9.6 million USD |
| 1997 | -6.5 million USD | 6.2 million USD |
| 1996 | -4.8 million USD | 400000 USD |
ABIO
Price: $3.26
52 week price:
Earnings Per Share: -0.37 USD
P/E Ratio: -4.32
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 21900
Ebitda: -14.2 millionMarket Capitalization: 44.8 million